A recent study published in Frontiers in Immunology discussed how injury and abnormal repair of the airway epithelium drive chronic obstructive pulmonary disease (COPD) and asthma. Study: Mechanisms ...
Current therapies for chronic obstructive pulmonary disease (COPD) alleviate symptoms, but do not deal with disease progression. Respiratory mucus is primarily made up of mucins, of which mucin 5AC ...
Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and a ...
Chronic obstructive pulmonary disease, or COPD, is one of the world’s leading causes of death, responsible for 3.5 million ...
Please provide your email address to receive an email when new articles are posted on . Potential benefits of nicotinamide riboside in COPD include lower lung inflammation and elevated nicotinamide ...
Chronic obstructive pulmonary disease (COPD) is among the most leading causes of death around the world and there are insufficient treatment options that prevent exacerbations or alter the progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results